Carmignac Gestion Cara Therapeutics, Inc. Transaction History

Carmignac Gestion

$5.82 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$11.55 - $16.06 $1.69 Million - $2.35 Million	-146,135 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$12.38 - $29.19 $13.7 Million - $32.3 Million	-1,105,073 Reduced 88.32%	146,135 $2.09 Million
Q1 2021 May 14, 2021	SELL	$15.07 - $21.71 $9.05 Million - $13 Million	-600,235 Reduced 32.42%	1,251,208 $27.2 Million
Q4 2020 Feb 12, 2021	SELL	$12.72 - $16.16 $689,894 - $876,469	-54,237 Reduced 2.85%	1,851,443 $28 Million
Q3 2020 Nov 13, 2020	SELL	$12.34 - $17.92 $1.97 Million - $2.86 Million	-159,473 Reduced 7.72%	1,905,680 $24.3 Million
Q2 2020 Aug 13, 2020	BUY	$12.39 - $17.33 $3.45 Million - $4.82 Million	278,091 Added 15.56%	2,065,153 $35.3 Million
Q1 2020 May 14, 2020	BUY	$9.12 - $17.78 $8.01 Million - $15.6 Million	878,492 Added 96.69%	1,787,062 $23.6 Million
Q4 2019 Feb 13, 2020	BUY	$16.11 - $25.98 $8.6 Million - $13.9 Million	533,622 Added 142.32%	908,570 $14.6 Million
Q3 2019 Nov 13, 2019	SELL	$18.28 - $26.91 $5.08 Million - $7.48 Million	-277,794 Reduced 42.56%	374,948 $6.85 Million
Q2 2019 Aug 13, 2019	BUY	$17.68 - $21.57 $3.87 Million - $4.72 Million	218,775 Added 50.41%	652,742 $14 Million
Q1 2019 May 14, 2019	BUY	$14.41 - $19.64 $515,460 - $702,542	35,771 Added 8.98%	433,967 $8.51 Million
Q4 2018 Feb 13, 2019	SELL	$12.45 - $23.47 $1.27 Million - $2.4 Million	-102,385 Reduced 20.45%	398,196 $5.18 Million
Q3 2018 Nov 13, 2018	SELL	$17.57 - $23.95 $1.82 Million - $2.48 Million	-103,691 Reduced 17.16%	500,581 $12 Million
Q2 2018 Aug 13, 2018	BUY	$11.6 - $19.27 $7.01 Million - $11.6 Million	604,272 New	604,272 $11.6 Million

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

2.25M
Shares

$11 Million
0.0% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$8.31 Million
0.06% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$7.59 Million
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.11M
Shares

$5.43 Million
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.11M
Shares

$5.41 Million
0.0% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Carmignac Gestion with notifications on news.

Account